Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study

Reducing levels of low-density lipoprotein cholesterol (LDL-C) below recommended thresholds is a core component of cardiovascular prevention strategies. We hypothesized that the addition of bempedoic acid to patients already on statin–ezetimibe therapy was more effective than titrating the statin do...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Giuseppe Marazzi, Giuseppe Caminiti, Marco Alfonso Perrone, Giuseppe Campolongo, Luca Cacciotti, Domenico Mario Giamundo, Ferdinando Iellamo, Paolo Severino, Maurizio Volterrani, Giuseppe Rosano
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-09-01
Edice:	Journal of Cardiovascular Development and Disease
Témata:	bempedoic acid hypercolesterolemia primary prevention statins ezetimibe
On-line přístup:	https://www.mdpi.com/2308-3425/11/9/286
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!